These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1088 related items for PubMed ID: 8720310

  • 1. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 2. Effect of the histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3'-[2-[[[5-methylamino ) methyl-2-furyl] methyl]thio]ethyl]-2"-(methylsulfonyl)guanidine on acute gastric mucosal injury in rats and its free-radical scavenging activities.
    Naito Y, Yoshikawa T, Matsuyama K, Yagi N, Nakamura Y, Nishimura S, Kaneko T, Yoshida N, Kondo M.
    Arzneimittelforschung; 1997 Jul; 47(7):845-8. PubMed ID: 9272243
    [Abstract] [Full Text] [Related]

  • 3. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H, Hamada K, Taga F, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [Abstract] [Full Text] [Related]

  • 4. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

  • 5. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
    Tanaka J, Iida H, Abe M, Yuda Y, Inoue S, Okabe S.
    Arzneimittelforschung; 2004 Sep; 54(4):221-9. PubMed ID: 15146935
    [Abstract] [Full Text] [Related]

  • 6. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [Abstract] [Full Text] [Related]

  • 7. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
    Tanaka T, Bickel M, Herling AW, Sakurai M, Goto M, Hayashi S.
    Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
    [Abstract] [Full Text] [Related]

  • 8. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [Abstract] [Full Text] [Related]

  • 9. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M, Isobe Y, Arai I, Hirose-Kijima H, Usuki-Ito C, Nagai H, Aihara H, Otomo S.
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [Abstract] [Full Text] [Related]

  • 10. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M, Kurebayashi Y, Ryokawa Y, Hashizume T, Akashi A.
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [Abstract] [Full Text] [Related]

  • 11. Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
    Inoie M, Marubuchi S, Arai H.
    Jpn J Pharmacol; 1998 Nov; 78(3):313-22. PubMed ID: 9869265
    [Abstract] [Full Text] [Related]

  • 12. [Synthesis and antiulcer activity of N-2-(2-hydroxy-2-phenyl)ethyl-N"-(methanesulfonyl)guanidine analogue of ranitidine. Development of a new antiulcer agent T-593].
    Shibata H, Kusayanagi Y, Arai H, Hashiba K, Yamamoto Y, Onoda M.
    Yakugaku Zasshi; 1998 Mar; 118(3):88-104. PubMed ID: 9549432
    [Abstract] [Full Text] [Related]

  • 13. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L, Russell J, Rimele TJ, Grimes D, Failli A, Mir GN.
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [Abstract] [Full Text] [Related]

  • 14. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M, Sakuma H, Shiratsuchi K, Mieda M.
    Arzneimittelforschung; 1985 Mar; 35(5):844-8. PubMed ID: 2862875
    [Abstract] [Full Text] [Related]

  • 15. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H, Ito H, Higaki M, Higaki M, Matsumoto Y, Kamimura T, Katsura Y, Tomishi T, Inoue Y, Takasugi H, Tomoi M, Krakowka S, Yoshida K.
    Eur J Pharmacol; 1999 Aug 13; 378(3):299-310. PubMed ID: 10493106
    [Abstract] [Full Text] [Related]

  • 16. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y, Nagai H, Muramatsu M, Aihara H, Otomo S.
    J Pharmacol Exp Ther; 1990 Dec 13; 255(3):1078-82. PubMed ID: 1979811
    [Abstract] [Full Text] [Related]

  • 17. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N, Hirata T, Inada I, Satoh H, Sino A, Maki Y.
    Arzneimittelforschung; 1985 Dec 13; 35(10):1553-9. PubMed ID: 4074415
    [Abstract] [Full Text] [Related]

  • 18. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H, Hamada K, Aijima H, Taga F, Uchida H, Nishino K.
    Arzneimittelforschung; 1993 Feb 13; 43(2):139-43. PubMed ID: 8096134
    [Abstract] [Full Text] [Related]

  • 19. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
    Ueda F, Aratani S, Mimura K, Kimura K, Nomura A, Enomoto H.
    Arzneimittelforschung; 1984 Feb 13; 34(4):474-7. PubMed ID: 6540106
    [Abstract] [Full Text] [Related]

  • 20. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S, Takagi K, Igata H, Kato S, Shimosako K, Yamaji Y, Seiki M.
    Jpn J Pharmacol; 1992 Jul 13; 59(3):275-89. PubMed ID: 1359178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.